Emergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?

Insider buying vs selling

Have Emergent Biosolutions Inc insiders been buying or selling?
Coleen GlessnerEVP Quality Ethics and CPL2024-06-081,249$6.19
Paul Anthony WilliamsSVP Products Business2024-06-08464$6.19
Richard S. LindahlEVP Chief Financial Officer2024-06-082,733$6.19
Jennifer Lynne FoxEVP Ext Aff GC Corp Sec2024-06-082,376$6.19
William HartzelSVP Bioservices2024-06-081,167$6.19
Kathryn C. ZoonDirector2024-06-0410,000$6.11
Kathryn C. ZoonDirector2024-05-291,830$4.61
Kathryn C. ZoonDirector2024-05-211,089$5.78
William HartzelSVP Bioservices2024-04-07665$2.29
Coleen GlessnerEVP Quality Ethics and CPL2024-04-07585$2.29

1 of 3

EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EBS insiders and whales buy or sell their stock.

EBS Shareholders

What type of owners hold Emergent Biosolutions Inc stock?
Fuad Elhibri49.11%25,733,310$154.66MInsider
Blackrock Inc13.47%7,060,208$42.43MInstitution
Intervac LLC8.29%4,344,250$26.11MInsider
Charles Schwab Investment Management Inc7.92%4,151,319$24.95MInstitution
Vanguard Group Inc6.51%3,411,549$20.50MInstitution
Biopharm LLC4.32%2,265,043$13.61MInsider
Robert Calvin Myers3.69%1,934,849$11.63MInsider
Avidity Partners Management LP3.64%1,908,000$11.47MInstitution
Biovac LLC3.05%1,599,155$9.61MInsider
Apax Europe Iv GP Co Ltd2.78%1,455,361$8.75MInsider

1 of 3

EBS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EBS42.29%57.71%Net SellingNet Selling
ORGO6.06%93.94%Net SellingNet Buying

Emergent Biosolutions Stock Ownership FAQ

Who owns Emergent Biosolutions?

Emergent Biosolutions (NYSE: EBS) is owned by 68.54% institutional shareholders, 93.52% Emergent Biosolutions insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Emergent Biosolutions shareholder, owning 25.73M shares representing 49.11% of the company. Fuad Elhibri's Emergent Biosolutions shares are currently valued at $155.94M.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.